Comments on: AZ’s First Corporate Blog Falls Flat http://blog.pharmexec.com/2009/11/04/2az%e2%80%99s-first-corporate-blog-falls-flat/ The Business of Pharmaceuticals Wed, 10 Mar 2010 16:21:20 -0500 hourly 1 By: pharmagossip http://blog.pharmexec.com/2009/11/04/2az%e2%80%99s-first-corporate-blog-falls-flat/comment-page-1/#comment-48688 pharmagossip Wed, 04 Nov 2009 22:08:19 +0000 http://blog.pharmexec.com/?p=1142#comment-48688 PS I also posted it as a comment on the blog - I'm not holding my breath for it to be published! LOL PS

I also posted it as a comment on the blog – I’m not holding my breath for it to be published! LOL

]]> By: pharmagossip http://blog.pharmexec.com/2009/11/04/2az%e2%80%99s-first-corporate-blog-falls-flat/comment-page-1/#comment-48686 pharmagossip Wed, 04 Nov 2009 22:06:14 +0000 http://blog.pharmexec.com/?p=1142#comment-48686 I've posted a Google SideWiki on the blog: Question 1. How much did Dave Brennan know about "The Seroquel Issue" at the time? http://pharmagossip.blogspot.com/2009/10/astrazeneca-to-pay-520-million-to.html The pharmaceutical company AstraZeneca said Thursday (29/Oct/09) that it had reached a $520 million agreement to settle two federal investigations and two whistle-blower lawsuits over the sale and marketing of its blockbuster psychiatric drug Seroquel. One of the investigations related to “selected physicians who participated in clinical trials involving Seroquel,” AstraZeneca disclosed in a government filing. The other case related to off-label promotion of the drug. H. Waxman's letter: http://oversight.house.gov/Documents/20070305175741-03469.pdf The Zoladex issue: http://www.justice.gov/opa/pr/2003/June/03_civ_371.htm I’ve posted a Google SideWiki on the blog:

Question 1. How much did Dave Brennan know about “The Seroquel Issue” at the time?

http://pharmagossip.blogspot.com/2009/10/astrazeneca-to-pay-520-million-to.html

The pharmaceutical company AstraZeneca said Thursday (29/Oct/09) that it had reached a $520 million agreement to settle two federal investigations and two whistle-blower lawsuits over the sale and marketing of its blockbuster psychiatric drug Seroquel.

One of the investigations related to “selected physicians who participated in clinical trials involving Seroquel,” AstraZeneca disclosed in a government filing. The other case related to off-label promotion of the drug.

H. Waxman’s letter:

http://oversight.house.gov/Documents/20070305175741-03469.pdf

The Zoladex issue:

http://www.justice.gov/opa/pr/2003/June/03_civ_371.htm

]]>